Pediatric T Cell ALL-Leukemia: Raising Awareness- Bluesun Foundation

Pediatric T Cell ALL-Leukemia: Raising Awareness- Bluesun Foundation Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers.

The annual incidence of acute lymphoblastic leukemia within the United States is 3.7-4.9 cases per 100,000 children age 0-14 years,[1] with a peak incidence in children aged 2-5 years. With improvements in diagnosis and treatment, overall cure rates for children with acute lymphoblastic leukemia have reached 90%.[3] The use of risk-adapted treatment protocols has improved cure rates while limiting the toxicity of therapy. This article summarizes the current diagnosis and treatment of childhood acute lymphoblastic leukemia. In acute lymphoblastic leukemia (ALL), a lymphoid progenitor cell becomes genetically altered and subsequently undergoes dysregulated proliferation, with clonal expansion. In ALL, the transformed lymphoid cells reflect the altered expression of genes usually involved in the normal development of B cells and T cells. Several studies indicate that leukemic stem cells are present in certain types of acute lymphoblastic leukemia. Fore more info on childhood Leukemia classifications : http://www.cancer.org/cancer/leukemiainchildren/detailedguide/childhood-leukemia-how-classified

Great News!!!
01/25/2020

Great News!!!

"Previously nobody believed this could be possible."

12/05/2019

Researchers have identified about a dozen unique syndromes for hereditary leukemia, which can cause different types of leukemia and related conditions, including acute myeloid leukemia, myelodysplastic syndromes, acute lymphoblastic leukemia and chronic lymphoblastic leukemia. Here's what to know.

12/04/2019

Only 1.5% of children with acute lymphoblastic leukemia who went without cranial radiation had a recurrence in the central nervous system, according to a recent trial. The therapy, which is intended to prevent such a recurrence, can produce devastating side effects.

Great news!!!
11/26/2019

Great news!!!

The U.N.’s global health agency is working with St. Jude to test a program in seven countries in Africa, Asia and South America.

Exciting....
10/29/2019

Exciting....

Results are in from a ten-year long clinical trial aimed at preventing relapse in pediatric patients with acute lymphoblastic leukemia.

Oh wow!!!
03/15/2019

Oh wow!!!

Read how the rush to create new, profitable drugs is jeopardizing the production of proven, older drugs that treat children with cancer.

Sorry for posting the original story. I have taken it off.
02/01/2019

Sorry for posting the original story. I have taken it off.

An Israeli company claimed it will cure cancer in a year, and the internet erupted. But in this latest viral incident, everyone loses.

12/13/2018

A new model explains key factors in chronic pain development, and future pain research designed to answer overlooked questions

Hats off Kids!!!!
11/20/2018

Hats off Kids!!!!

The Auburn University Marching Band collaborated with Coach Bruce Pearl's AUtLive program to create this halftime show to spread awareness of cancer and high...

Obesity starts with therapy for ALL in children. New study
10/30/2018

Obesity starts with therapy for ALL in children. New study

A new study in the journal, Cancer, shows obesity problem starts during the early phase of therapy for children with acute lymphoblastic leukemia. http://ow.ly/fGok30mnlVm

Wonderful study!!!
09/14/2018

Wonderful study!!!

The hybrid cells promote tumor heterogeneity and possible metastasis, a new study in mice and humans shows.

Address

Plainfield, IL
60585

Alerts

Be the first to know and let us send you an email when Pediatric T Cell ALL-Leukemia: Raising Awareness- Bluesun Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pediatric T Cell ALL-Leukemia: Raising Awareness- Bluesun Foundation:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram